Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review by Manon Hustinx, Ann-Marie Shorrocks, Laurent Servais

Subjects: Get full text

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY by I. V. Shirinsky, O. I. Zheltova, V. S. Shirinsky, V. A. Kozlov

Subjects: Get full text

Update on immunopathogenesis and immunotherapy in multiple sclerosis by Selter RC, Hemmer B

Subjects: Get full text

Adherence to disease modifying therapies in patients with multiple sclerosis by D. Pileckė, N. Giedraitienė

Subjects: Get full text

Disease-Modifying Therapy for Transthyretin Amyloidosis by Nowell M. Fine, MD, SM

Subjects: Get full text

Glycyrrhizin as a potential disease-modifying therapy for epilepsy: insights into targeting pyroptosis to exert neuroprotective and anticonvulsant effects by Lei Wei, Sijie Ou, Youshi Meng, Lanfeng Sun, Lin Zhang, Yuling Lu, Yuan Wu

Subjects: Get full text

Multiple sclerosis in pregnancy. Treatment options and outcomes: a review by Delia Cudalba, Nicolae Gica, Gheorghe Peltecu, Radu Botezatu, Anca Maria Panaitescu

Subjects: Get full text

Promises and pitfalls of immune-based strategies for Huntington's disease by Gabriela Delevati Colpo, Erin Furr Stimming, Natalia Pessoa Rocha, Antonio Lucio Teixeira

Subjects: “…Huntington′s disease; treatment; disease modifying therapy; inflammation…”
Get full text

Outcomes of pregnancy in Egyptian women with multiple sclerosis in the new treatment era: a multi-center retrospective observational study by Ali Mahmoud Ahmed, Mohamed Al-Bahay M. G. Reda, Ahmed Hassan Elsheshiny

Subjects: Get full text

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS by E E Gubar', A G Bochkova, N V Bunchuk, E E Gubar, A G Bochkova, N V Bunchuk

Subjects: Get full text

Knowledge domain and trend of disease-modifying therapies for multiple sclerosis: A study based on CiteSpace by Ting Zheng, Taotao Jiang, Zilong Huang, Manxia Wang

Subjects: Get full text

The Effects of Multiple Sclerosis and Disease Modifying Therapy on Pregnancy by Tarneer Kaur Johal

Subjects: Get full text

Factors Associated with Therapeutic Adherence in Multiple Sclerosis in Spain by Soria C, Prieto L, Lázaro E, Ubeda A

Subjects: Get full text

Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort by Melesse DY, Marrie RA, Blanchard JF, Yu BN, Evans C

Subjects: Get full text

Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses by Yaser M. Al Malik, Ibtisam A. Al Thubaiti, Maha A. AlAmmari, Norah Al Fugham, Eman N. Ali, Dema A. Alissa, Salman A. Aljarallah, Ahmed H. Al-Jedai, Maeed A. AlKathiri, Mona M. AlKhawajah, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Hessa S. Al Otaibi, Ghadah H. AlTowaijri, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Saeed A. Bohlega, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Abid M. Kareem, Amr M. Khardaly, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammad A. Al Jumah

Subjects: Get full text

Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study) by Annette F. Okai, Lilyana Amezcua, Regina R. Berkovich, Angel R. Chinea, Keith R. Edwards, Brian Steingo, Aljoeson Walker, Alan K. Jacobs, Nadia Daizadeh, Mitzi J. Williams, the CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators

Subjects: Get full text

Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy’s Impact on Disease Activity by Guoda Varytė, Jolita Zakarevičienė, Diana Ramašauskaitė, Dalia Laužikienė, Audronė Arlauskienė

Subjects: Get full text

Therapeutic Advances in Multiple Sclerosis by Jennifer H. Yang, Torge Rempe, Natalie Whitmire, Anastasie Dunn-Pirio, Jennifer S. Graves

Subjects: Get full text

MicroRNAs as a possible biomarker in the treatment of multiple sclerosis by Moisés Manuel Gallardo Pérez, Solón Javier Garcés Eisele

Subjects: Get full text

Leflunomide (Arava) in early rheumatoid arthritis by R V Balabanova, D E Karateev, R YKashevarov, E L Luchihina

Subjects: Get full text